[3 pregnancies carried to term following vaginal administration of 3 mg prostaglandin E 2 in the 1st trimester].
In the years 1985 and 1986 three women decided in the last minute not to undergo a planned abortion after vaginal application of prostaglandin E 2 twenty-four hours before the intended operation. These women came to our genetic clinic in order to obtain some information on the teratogenic risks of prostaglandins applied during early pregnancy. On the basis of these consultation and risk assessment, all three women decided to continue their pregnancy, resulting in the delivery of a healthy child in each case.
Tews
G
G
Landes-Frauenklinik Linz.
Arzt
W
W
D000014:Abnormalities, Drug-Induced / Q000209:etiology*; D000019:Abortifacient Agents / Q000009:adverse effects; D000020:Abortifacient Agents, Nonsteroidal / Q000009:adverse effects; D000028:Abortion, Induced; D000282:Administration, Intravaginal; D015232:Dinoprostone; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D011458:Prostaglandins E / Q000009:adverse effects; D012307:Risk Factors
D000019:Abortifacient Agents; D000020:Abortifacient Agents, Nonsteroidal; D011458:Prostaglandins E; D015232:Dinoprostone
Drei ausgetragene Schwangerschaften nach vaginaler Applikation von 3 mg Prostaglandin E 2 im I. Trimenon.